One Mind Brain Health Impact Fund

One Mind Brain Health Impact Fund

The One Mind Brain Health Impact Fund operates as an impact-oriented investment vehicle focused on brain health. Founded within the broader One Mind nonprofit ecosystem, the fund targets scalable solutions for brain injury, mental health, and neurodegenerative disease. Its structure ties capital deployment to measurable health outcomes, aligning commercial returns with the mission of advancing neuroscience access and treatment. The fund invests across early-stage therapeutic platforms, digital diagnostics, and AI-driven mental health tools. Its portfolio includes companies such as Alto Neuroscience and Mindstrong Health. Geographically, the fund focuses on North America, with a particular emphasis on the United States ecosystem of academic spinouts and venture-backed neurotech startups. The fund also participates in co-investments alongside syndicates and venture funds active in biotech and digital health. The fund's team of professionals spans offices in Chicago, Los Angeles, Larkspur, and Boston. While total AUM and number of professionals remain undisclosed, the fund's multi-city footprint suggests a distributed deal-sourcing model. The broader One Mind organization runs the One Mind Accelerator, a 90-day program for early-stage brain health startups, which feeds deal flow into the Impact Fund. In 2024, the accelerator graduated its fourth cohort, signaling sustained origination activity (per One Mind, 2024). The fund's structural differentiator is its integration with a nonprofit parent — One Mind — which provides a platform for clinical validation, advocacy, and patient access. This model allows the fund to de-risk investments through the nonprofit's research network and regulatory connections. The fund's governance likely separates philanthropic grant-making from for-profit investments, a structure familiar to impact funds operating within larger family office ecosystems.